OBJECTIVE: Sialic acids frequently occur at the terminal positions of glycoprotein N-glycans present at chondrocyte surfaces or in the cartilage matrix. Sialic acids are transferred to glycoproteins in either alpha-2,3 or alpha-2,6 linkage by specific sialyltransferases (SiaTs) and can potentially affect cell functions and cell-matrix interactions. The present study aimed to assess the relationship between the expression of the human chondrocyte phenotype and the sialylation of chondrocyte glycoprotein N-glycans. METHODS: The transcription of 5 SiaT was quantified using real-time Reverse transcription polymerase chain reaction (RT-PCR) assays. N-glycan analysis was performed using LC-ESI-MS. Primary human chondrocytes were cultured in monolayer or alginate beads and compared to the chondrocyte cell lines C-28/I2 and SW1353. In addition, effects of interleukin-1beta (IL-1beta) or tumour necrosis factor-alpha (TNF-alpha) on primary cells were assessed. RESULTS: Primary human chondrocytes predominantly express alpha-2,6-specific SiaTs and accordingly, alpha-2,6-linked sialic acid residues in glycoprotein N-glycans. In contrast, the preponderance of alpha-2,3-linked sialyl residues and, correspondingly, reduced levels of alpha-2,6-specific SiaTs are associated with the altered chondrocyte phenotype of C-28/I2 and SW1353 cells. Importantly, a considerable shift towards alpha-2,3-linked sialic acids and alpha-2,3-specific SiaT mRNA levels occurred in primary chondrocytes treated with IL-1beta or tumour necrosis factor-alpha (TNF-alpha). CONCLUSION: The expression of the differentiated chondrocyte phenotype is linked to the ratio of alpha-2,6- to alpha-2,3-linked sialic acids in chondrocyte glycoprotein N-glycans. A shift towards altered sialylation might contribute to impaired cell-matrix interactions in disease conditions. Copyright 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
OBJECTIVE:Sialic acids frequently occur at the terminal positions of glycoprotein N-glycans present at chondrocyte surfaces or in the cartilage matrix. Sialic acids are transferred to glycoproteins in either alpha-2,3 or alpha-2,6 linkage by specific sialyltransferases (SiaTs) and can potentially affect cell functions and cell-matrix interactions. The present study aimed to assess the relationship between the expression of the humanchondrocyte phenotype and the sialylation of chondrocyte glycoprotein N-glycans. METHODS: The transcription of 5 SiaT was quantified using real-time Reverse transcription polymerase chain reaction (RT-PCR) assays. N-glycan analysis was performed using LC-ESI-MS. Primary humanchondrocytes were cultured in monolayer or alginate beads and compared to the chondrocyte cell lines C-28/I2 and SW1353. In addition, effects of interleukin-1beta (IL-1beta) or tumour necrosis factor-alpha (TNF-alpha) on primary cells were assessed. RESULTS: Primary humanchondrocytes predominantly express alpha-2,6-specific SiaTs and accordingly, alpha-2,6-linked sialic acid residues in glycoprotein N-glycans. In contrast, the preponderance of alpha-2,3-linked sialyl residues and, correspondingly, reduced levels of alpha-2,6-specific SiaTs are associated with the altered chondrocyte phenotype of C-28/I2 and SW1353cells. Importantly, a considerable shift towards alpha-2,3-linked sialic acids and alpha-2,3-specific SiaT mRNA levels occurred in primary chondrocytes treated with IL-1beta or tumour necrosis factor-alpha (TNF-alpha). CONCLUSION: The expression of the differentiated chondrocyte phenotype is linked to the ratio of alpha-2,6- to alpha-2,3-linked sialic acids in chondrocyte glycoprotein N-glycans. A shift towards altered sialylation might contribute to impaired cell-matrix interactions in disease conditions. Copyright 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Authors: S Toegel; N Harrer; V E Plattner; F M Unger; H Viernstein; M B Goldring; F Gabor; M Wirth Journal: J Control Release Date: 2006-10-06 Impact factor: 9.776
Authors: Heidi Hemmoranta; Tero Satomaa; Maria Blomqvist; Annamari Heiskanen; Olli Aitio; Juhani Saarinen; Jari Natunen; Jukka Partanen; Jarmo Laine; Taina Jaatinen Journal: Exp Hematol Date: 2007-08 Impact factor: 3.084
Authors: Dubravko Rendić; Iain B H Wilson; Gert Lubec; Martin Gutternigg; Friedrich Altmann; Renaud Léonard Journal: Electrophoresis Date: 2007-12 Impact factor: 3.535
Authors: Shengqian Q Wu; Miguel Otero; Frank M Unger; Mary B Goldring; Ampai Phrutivorapongkul; Catharina Chiari; Alexander Kolb; Helmut Viernstein; Stefan Toegel Journal: J Ethnopharmacol Date: 2011-09-21 Impact factor: 4.360
Authors: Martin Pabst; Simon Karl Küster; Fabian Wahl; Jasmin Krismer; Petra S Dittrich; Renato Zenobi Journal: Mol Cell Proteomics Date: 2015-03-23 Impact factor: 5.911
Authors: Mario Rothbauer; Eva I Reihs; Anita Fischer; Reinhard Windhager; Florien Jenner; Stefan Toegel Journal: Front Bioeng Biotechnol Date: 2022-06-15
Authors: Paula Carpintero-Fernandez; Marta Varela-Eirin; Alessandra Lacetera; Raquel Gago-Fuentes; Eduardo Fonseca; Sonsoles Martin-Santamaria; Maria D Mayan Journal: Biomolecules Date: 2020-04-21
Authors: Stefan Toegel; Daniela Bieder; Sabine André; Friedrich Altmann; Sonja M Walzer; Herbert Kaltner; Jochen G Hofstaetter; Reinhard Windhager; Hans-Joachim Gabius Journal: Arthritis Res Ther Date: 2013-10-04 Impact factor: 5.156